Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects
Author:
Affiliation:
1. Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine and Hospital Seoul Korea
2. Department of Clinical Pharmacology and Therapeutics Hanyang University Hospital Seoul Korea
3. Roche Korea Seoul Korea
Publisher
Wiley
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13160
Reference28 articles.
1. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
2. World Health Organization.Influenza. Accessed October 1 2020.
3. Economic burden of seasonal influenza in the United States
4. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains
5. Influenza antivirals currently in late-phase clinical trial
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Simultaneous quantification of baloxavir marboxil and its active metabolite in human plasma using UHPLC-MS/MS: Application to a human pharmacokinetic study with different anticoagulants;Journal of Pharmaceutical and Biomedical Analysis;2024-10
2. A real-world disproportionality analysis of Baloxavir Marboxil: post-marketing pharmacovigilance data;Expert Opinion on Drug Safety;2024-09-05
3. Retracted and republished from: “The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs”;mBio;2024-05-08
4. Determination of a novel anti‐influenza pinanamine‐based analog in rat plasma by liquid chromatography‐tandem mass spectrometry and its application in pharmacokinetic evaluations;SEPARATION SCIENCE PLUS;2024-02-19
5. The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs;mBio;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3